1,580 followers
Reporting neg studies is important IGFR MoAB in pts with refractory CRC - no benefit in phase II trial http://t.co/7eiRwV5sga #SWOGOnc
Reporting neg studies is important IGFR MoAB in pts with refractory CRC - no benefit in phase II trial http://t.co/7eiRwV5sga #SWOGOnc